Carmen Mak

Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

John G. McHutchison, Michael P. Manns, Keyur Patel et al. · Gastroenterology · 2002 · 977 citations · Full text

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +12

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Jennifer L. McQuade, Carrie R. Daniel, Kenneth R. Hess et al. · The Lancet Oncology · 2018 · 658 citations · Full text

Medicine, Dermatology, Oncology +14

Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials

Georgina V. Long, Jean‐Jacques Grob, Paul Nathan et al. · The Lancet Oncology · 2016 · 312 citations

Medicine, Oncology, Pharmacology +16

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Mark Sulkowski, Stanislas Pol, Josep Mallolas et al. · The Lancet Infectious Diseases · 2013 · 182 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

A modified score function estimator for multinomial logistic regression in small samples

Shelley B. Bull, Carmen Mak, Celia M.T. Greenwood · Computational Statistics & Data Analysis · 2002 · 94 citations

Education, Biostatistics, Econometrics +7